Tin tức & Cập nhật

Chỉ hiển thị Multimedia

Pre-op tiragolumab plus atezolizumab viable in advanced NSCLC

04 Nov 2025 bởi

Neoadjuvant treatment with tiragolumab plus atezolizumab, with or without chemotherapy, is feasible in advanced resectable non-small cell lung cancer (NSCLC), having an acceptable safety profile and yielding major pathologic response (MPR) rates comparable to that observed with other perioperative immunotherapy plus chemotherapy regimens, according to the phase II SKYSCRAPER-05 trial.

Pre-op tiragolumab plus atezolizumab viable in advanced NSCLC

04 Nov 2025

DNMT3A mutations predict PD-(L)1 blockade efficacy in NSCLC

04 Nov 2025

Some patients with nonsmall-cell lung cancer (NSCLC) have somatic DNA methyltransferase 3A (DNMT3A) mutations, which are associated with a reduced DNMT3A expression and a favourable immunophenotype, reveals a study.

DNMT3A mutations predict PD-(L)1 blockade efficacy in NSCLC

04 Nov 2025

Patients with advanced NSCLC get durable benefits with frontline cemiplimab plus chemo

03 Nov 2025 bởi

In the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC), the combination of cemiplimab plus chemotherapy continued to provide superior benefits compared with chemotherapy alone, according to 5-year data from the phase III EMPOWER-Lung part 2 trial.

Patients with advanced NSCLC get durable benefits with frontline cemiplimab plus chemo

03 Nov 2025

Past COVID-19 infection linked to poor sleep

02 Nov 2025

People with a history of COVID-19 appear to have reduced sleep quality, as reported in a study.

Past COVID-19 infection linked to poor sleep

02 Nov 2025

Plant-based foods, probiotic drinks may help fight allergic asthma

02 Nov 2025 bởi

Certain plant-based foods and probiotic drinks appear to be associated with reduced prevalence of allergic asthma among young Chinese adults in Singapore, according to a study.

Plant-based foods, probiotic drinks may help fight allergic asthma

02 Nov 2025

Original New Drug Application Approvals by US FDA (16-30 September 2025)

31 Oct 2025

New drug applications approved by US FDA as of 16-30 September 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-30 September 2025)

31 Oct 2025

Colchicine flops for long COVID treatment

29 Oct 2025

Treatment with colchicine does not appear to improve functional capacity, respiratory function, or inflammatory markers in adults with long COVID, as shown in a study.

Colchicine flops for long COVID treatment

29 Oct 2025

Does morphine use help with breathlessness?

24 Oct 2025

Treatment with oral morphine falls short of improving breathlessness due to cardiorespiratory conditions, as shown in a study.

Does morphine use help with breathlessness?

24 Oct 2025

EzPAP device bests noninvasive ventilation for hypercapnic COPD exacerbations

24 Oct 2025 bởi

In the treatment of patients with mild-to-moderate hypercapnic exacerbations of chronic obstructive pulmonary disease (COPD), the EzPAP positive airway pressure device works better than noninvasive ventilation at improving oxygen saturation levels and correcting respiratory acidosis, as shown in a study.

EzPAP device bests noninvasive ventilation for hypercapnic COPD exacerbations

24 Oct 2025

Infant antibiotic use ups risks of asthma, later infections

23 Oct 2025 bởi

Early use of antibiotics among children may lead to several health concerns, including asthma and later infections during childhood years, suggests a study.

Infant antibiotic use ups risks of asthma, later infections

23 Oct 2025

Tin tức & Cập nhật

Xem bài viết Hô hấp

Xem

Chuyên ngành:

Pre-op tiragolumab plus atezolizumab viable in advanced NSCLC

Pre-op tiragolumab plus atezolizumab viable in advanced NSCLC

DNMT3A mutations predict PD-(L)1 blockade efficacy in NSCLC

DNMT3A mutations predict PD-(L)1 blockade efficacy in NSCLC

Patients with advanced NSCLC get durable benefits with frontline cemiplimab plus chemo

Patients with advanced NSCLC get durable benefits with frontline cemiplimab plus chemo

Past COVID-19 infection linked to poor sleep

Past COVID-19 infection linked to poor sleep

Plant-based foods, probiotic drinks may help fight allergic asthma

Plant-based foods, probiotic drinks may help fight allergic asthma

Original New Drug Application Approvals by US FDA (16-30 September 2025)

Original New Drug Application Approvals by US FDA (16-30 September 2025)

Colchicine flops for long COVID treatment

Colchicine flops for long COVID treatment

Does morphine use help with breathlessness?

Does morphine use help with breathlessness?

EzPAP device bests noninvasive ventilation for hypercapnic COPD exacerbations

EzPAP device bests noninvasive ventilation for hypercapnic COPD exacerbations

Infant antibiotic use ups risks of asthma, later infections

Infant antibiotic use ups risks of asthma, later infections